BAM
MRNA icon

Blueshift Asset Management’s Moderna MRNA Stock Holding History

Blueshift Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,100
Closed -$423K – 1096
2021
Q3 		$423K Sell
1,100
-28,332
-96% -$10.4M 0.02% 688
2021
Q2 		$6.92M Buy
+29,432
New +$5.26M 0.38% 72
2021
Q1 		– Sell
-8,962
Closed -$936K – 993
2020
Q4 		$936K Buy
+8,962
New +$907K 0.11% 280
2020
Q3 		– Sell
-13,223
Closed -$849K – 714
2020
Q2 		$849K Buy
+13,223
New +$724K 0.14% 215
2020
Q1 		– Sell
-16,522
Closed -$323K – 495
2019
Q4 		$323K Buy
+16,522
New +$293K 0.04% 585

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Blueshift Asset Management's MRNA Position: Q4 2021 in Review

Blueshift Asset Management sold out of Moderna (MRNA) in Q4 2021, closing a stake of 1,100 shares — an estimated $423K sold.

Blueshift Asset Management first reported a position in MRNA in Q4 2019 and held it in 5 quarters. The position peaked at $6.92M in Q2 2021. 1,109 funds tracked by Wall St. Rank hold MRNA as of Q4 2021.

  • Blueshift Asset Management reported no remaining Moderna position as of Q4 2021 after selling out during the quarter.
  • Blueshift Asset Management sold 1,100 Moderna shares in Q4 2021, an estimated $423K.
  • Blueshift Asset Management first reported a position in Moderna in Q4 2019 and held it in 5 quarters.
  • Blueshift Asset Management's Moderna position peaked at $6.92M in Q2 2021.
  • 1,109 funds tracked by Wall St. Rank held Moderna as of Q4 2021.

Based on Blueshift Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.